Dimerix Limited (ASX:DXB)
0.5950
-0.0150 (-2.46%)
May 13, 2025, 4:10 PM AEST
Dimerix Revenue
Dimerix had revenue of 287.45K AUD in the half year ending December 31, 2024. This brings the company's revenue in the last twelve months to 737.87K, up 334.43% year-over-year. In the fiscal year ending June 30, 2024, Dimerix had annual revenue of 583.48K with 1,486.10% growth.
Revenue (ttm)
737.87K
Revenue Growth
+334.43%
P/S Ratio
462.48
Revenue / Employee
n/a
Employees
n/a
Market Cap
341.25M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Jun 30, 2024 | 583.48K | 546.69K | 1,486.10% |
Jun 30, 2023 | 36.79K | -6.43M | -99.43% |
Jun 30, 2022 | 6.46M | 2.02M | 45.58% |
Jun 30, 2021 | 4.44M | 2.10M | 89.65% |
Jun 30, 2020 | 2.34M | 893.56K | 61.74% |
Jun 30, 2019 | Pro | Pro | Pro |
Jun 30, 2018 | Pro | Pro | Pro |
Jun 30, 2017 | Pro | Pro | Pro |
Jun 30, 2016 | Pro | Pro | Pro |
Jun 30, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
CSL Limited | 24.61B |
Pro Medicus | 184.58M |
Cochlear | 2.31B |
Sonic Healthcare | 9.33B |
Ramsay Health Care | 17.12B |
Telix Pharmaceuticals | 783.21M |
Ansell | 3.00B |
Regis Healthcare | 1.10B |
Dimerix News
- 12 days ago - Biotech Dimerix lands $940m licensing deal for kidney drug sales - The Australian Financial Review